ECSP982775A - STABILIZED THERIPARATIDE SOLUTIONS - Google Patents
STABILIZED THERIPARATIDE SOLUTIONSInfo
- Publication number
- ECSP982775A ECSP982775A ECSP982775A ECSP982775A EC SP982775 A ECSP982775 A EC SP982775A EC SP982775 A ECSP982775 A EC SP982775A EC SP982775 A ECSP982775 A EC SP982775A
- Authority
- EC
- Ecuador
- Prior art keywords
- stabilized
- theriparatide
- solutions
- solution
- cresaol
- Prior art date
Links
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- 102000003982 Parathyroid hormone Human genes 0.000 abstract 2
- 108090000445 Parathyroid hormone Proteins 0.000 abstract 2
- 239000000199 parathyroid hormone Substances 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 208000000474 Poliomyelitis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 229960001319 parathyroid hormone Drugs 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 229940095064 tartrate Drugs 0.000 abstract 1
- OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta invención describe una composición farmacéutica estabilizada en la forma de una solución para la administración parenteral de una hormona paratiroidea donde el ingrediente terapéuticamente activo es estabilizado con un amortiguador y un polio). Las preparaciones preferidas contienen una solución acuosa humana PTH(1-34), manitol, un agente amortiguador acetato o tartrato y m-cresaol o bencilalchoho) como un conservante.This invention describes a stabilized pharmaceutical composition in the form of a solution for parenteral administration of a parathyroid hormone where the therapeutically active ingredient is stabilized with a buffer and a polio). Preferred preparations contain a human aqueous PTH (1-34) solution, mannitol, an acetate or tartrate buffering agent, and m-cresaol or benzyl alcohol) as a preservative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982775 ECSP982775A (en) | 1998-12-09 | 1998-12-09 | STABILIZED THERIPARATIDE SOLUTIONS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982775 ECSP982775A (en) | 1998-12-09 | 1998-12-09 | STABILIZED THERIPARATIDE SOLUTIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982775A true ECSP982775A (en) | 1999-05-17 |
Family
ID=42043694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982775 ECSP982775A (en) | 1998-12-09 | 1998-12-09 | STABILIZED THERIPARATIDE SOLUTIONS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982775A (en) |
-
1998
- 1998-12-09 EC ECSP982775 patent/ECSP982775A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9813463A (en) | Stabilized teriparatide solutions | |
| TW200735897A (en) | HFSH aqueous formulation | |
| EP1138314A3 (en) | Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues | |
| CL2010001416A1 (en) | Use of a composition for the supply of a bactericidal hormone, peptide or protein or peptide or insecticidal protein comprising a disabled algal cell expressing said hormone, peptide or protein to induce enhanced growth, antibacterial or insecticidal activity (div.sol.no. 1360-02). | |
| AR098830A2 (en) | WATERPROOF SUSPENSIONS STABILIZED FOR PARENTERAL ADMINISTRATION | |
| PL379867A1 (en) | Controlled release delivery system for nasal applications | |
| AR044147A1 (en) | STABILIZED AND HSA-FREE INTERFER LIQUID FORMULATIONS | |
| CO6361907A2 (en) | FARMACO TRANSDERMIC SUPPLY USING AN OSMOLIT AND A VASOACTIVE AGENT | |
| CY1109223T1 (en) | LIQUID PREPARATIONS TOY G-CSF | |
| MY129417A (en) | Zinc-free and low-zinc insulin preparations having improved stability | |
| DE60318867D1 (en) | SOLUTION FOR NAIL USE | |
| DE602006014990D1 (en) | INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN | |
| AR042815A1 (en) | ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS | |
| CR7614A (en) | INSULIN ACID PREPARATIONS WITH IMPROVED STABILITY | |
| NZ520015A (en) | Hydroxide-releasing agents as skin permeation enhancers | |
| AR062059A1 (en) | PHARMACEUTICAL FOAM WITH FATTY ACID | |
| ES2275716T3 (en) | PHARMACEUTICAL COMPOSITION OF TRANSDERMAL LIBERATION. | |
| BR0313627A (en) | Pharmaceutical formulations, processes for the preparation of pharmaceutical formulations and method for treating pain | |
| UY27378A1 (en) | PHARMACEUTICAL COMPOSITION | |
| ATE433746T1 (en) | INSULIN COMPOSITIONS WITH IMPROVED ACTIVE ABSORPTION | |
| WO2005007072A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| AR012217A1 (en) | A TOPICAL COMPOSITION TO IMPROVE THE PENETRATION OF PHARMACEUTICAL COMPOUNDS | |
| UA92146C2 (en) | Stabilized interferon liquid formulations | |
| TNSN07285A1 (en) | Anthelmintic composition | |
| CO5540279A2 (en) | LIOFILITATED FORMULATION OF 2-METHYL-TIENO-BENZODIAZEPINA |